ARCHIVES

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

When Is A Cancer Cured? NCI Suggest One-Year Survival Rates Useful In Determining Advances

August 1, 1975

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

DuBois Succeeds Hait As AACR President, Jacks Is President-Elect.

April 18, 2008

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998